Literature DB >> 24745361

A cure for HIV: is it in sight?

Matthew Pace1, John Frater.   

Abstract

HIV is a devastating disease affecting millions of people worldwide despite the advent of successful antiretroviral therapy (ART). However, ART does not result in a cure and has to be taken for life. Accordingly, researchers are turning towards cure efforts, particularly in the light of two patients whose HIV has been seemingly eradicated. Numerous approaches and strategies have been considered for curing HIV, but no scalable and safe solution has yet been reached. With newly discovered difficulties in measuring the HIV reservoir, the main barrier to a cure, the only true test of cure is to stop ART and see whether the virus becomes detectable. However, it is possible that this treatment interruption may be associated with certain risks for patients. Here, we compare the current major approaches and recent advances for curing HIV, as well as discuss ways of evaluating HIV cure and the safety concerns involved.

Entities:  

Keywords:  HIV; cure; functional; kick and kill; sterilising

Mesh:

Substances:

Year:  2014        PMID: 24745361     DOI: 10.1586/14787210.2014.910112

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  11 in total

Review 1.  Nanotechnology approaches for delivery of cytochrome P450 substrates in HIV treatment.

Authors:  Yuqing Gong; Pallabita Chowdhury; Prashanth K B Nagesh; Theodore J Cory; Chelsea Dezfuli; Sunitha Kodidela; Ajay Singh; Murali M Yallapu; Santosh Kumar
Journal:  Expert Opin Drug Deliv       Date:  2019-07-24       Impact factor: 6.648

2.  Epidemiology and Clinical Outcomes of HIV Infection in South-Central China: A Retrospective Study From 2003 to 2018.

Authors:  Tingting Yue; Pan Zhang; Yuantao Hao; Jianmei He; Jun Zheng; Erik De Clercq; Guangdi Li; Yaxiong Huang; Fang Zheng
Journal:  Front Public Health       Date:  2022-06-09

3.  Evaluation of a Novel In-house HIV-1 Genotype Drug Resistance Assay using Clinical Samples in China.

Authors:  Peijie Gao; Fengting Yu; Xiaozhen Yang; Dan Li; Yalun Shi; Yan Wang; Fujie Zhang
Journal:  Curr HIV Res       Date:  2022       Impact factor: 1.341

Review 4.  Towards an HIV-1 cure: measuring the latent reservoir.

Authors:  Katherine M Bruner; Nina N Hosmane; Robert F Siliciano
Journal:  Trends Microbiol       Date:  2015-03-05       Impact factor: 17.079

Review 5.  P-Selectin Glycoprotein Ligand 1: A Potential HIV-1 Therapeutic Target.

Authors:  Silvere D Zaongo; Yanqiu Liu; Vijay Harypursat; Fangzhou Song; Huan Xia; Ping Ma; Yaokai Chen
Journal:  Front Immunol       Date:  2021-08-09       Impact factor: 7.561

6.  Differential Diagnosis of Chorea-HIV Infection Delays Diagnosis of Huntington's Disease by Years.

Authors:  Jannis Achenbach; Simon Faissner; Carsten Saft
Journal:  Brain Sci       Date:  2021-05-27

7.  Histone Deacetylase Inhibitors Enhance CD4 T Cell Susceptibility to NK Cell Killing but Reduce NK Cell Function.

Authors:  Matthew Pace; James Williams; Ayako Kurioka; Andrew B Gerry; Bent Jakobsen; Paul Klenerman; Nneka Nwokolo; Julie Fox; Sarah Fidler; John Frater
Journal:  PLoS Pathog       Date:  2016-08-16       Impact factor: 6.823

Review 8.  The Role of Cyclodextrins in the Design and Development of Triterpene-Based Therapeutic Agents.

Authors:  Alexandra Prodea; Alexandra Mioc; Christian Banciu; Cristina Trandafirescu; Andreea Milan; Roxana Racoviceanu; Roxana Ghiulai; Marius Mioc; Codruta Soica
Journal:  Int J Mol Sci       Date:  2022-01-10       Impact factor: 5.923

9.  When to start paediatric testing of the adult HIV cure research agenda?

Authors:  Seema K Shah
Journal:  J Med Ethics       Date:  2016-06-03       Impact factor: 5.926

10.  Characterisation of a highly potent and near pan-neutralising anti-HIV monoclonal antibody expressed in tobacco plants.

Authors:  Catherine M Moore; Melanie Grandits; Clemens Grünwald-Gruber; Friedrich Altmann; Maria Kotouckova; Audrey Y-H Teh; Julian K-C Ma
Journal:  Retrovirology       Date:  2021-06-28       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.